Indwelling pleural catheter: Changing the paradigm of malignant effusion management

Journal of Thoracic Oncology

Volumn 6, Issue 4, 2011, Pages 655-657

  Lee, Y C Gary ^a   Fysh, Edward T H ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TALC;

EDITORIAL; HEALTH CARE PERSONNEL; HUMAN; INDWELLING CATHETER; PATIENT CARE; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 79952997975     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182114aa0     Document Type: Editorial

References (27)

1. Haas AR, Sterman DH, Musani A. Malignant pleural effusions. Chest 2007;132:1036-1041.
2. Mishra E, Davies HE, Lee YCG. Malignant pleural disease in primary lung cancer. In SG Spiro, SM Janes, RM Huber (Eds.), Thoracic Malignancies. Sheffield, UK: European Respiratory Society Journals Ltd, 2009. Pp. 318-335.
3. Davies HE, Steer H, Fysh E, et al. Diagnosis and management of malignant pleural effusions. Minerva Pneumol 2010;49:237-252.
4. Davies HE, Lee YCG, Davies RJO. Pleurodesis for malignant pleural effusion: talc, toxicity and what next? Thorax 2008;63:572-574. (Pubitemid 351969245)
5. Dresler CM, Olak J, Herndon JE 2nd, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005;127:909-915. (Pubitemid 40775523)
6. Maskell NA, Lee YCG, Gleeson FV, et al. Prospective randomized trials comparing the influence of talc of different particle sizes and tetracycline on lung and systemic inflammation after pleurodesis. Am J Respir Crit Care Med 2004;170:377-382. (Pubitemid 39214610)
7. Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007;369:1535-1539. (Pubitemid 46670303)
8. Suzuki K, Servais EL, Rizk NP, et al. Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters. J Thorac Oncol 2011;6:762-767.
9. Putnam JB, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000;69:369-375. (Pubitemid 30125561)
10. Tremblay A, Mason C, Michaud G. Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis. Eur Respir J 2007;30:759-762. (Pubitemid 351194838)
11. Musani A. Treatment options for malignant pleural effusion. Curr Opin Pulm Med 2009;15:380-387.
12. Warren WH, Kalimi R, Khodadadian LM, et al. Management of malig-nant pleural effusions using the pleurx catheter. Ann Thorac Surg 2008;85:1049-1055. (Pubitemid 351253535)
13. Wrightson JM, Fysh E, Maskell NA, et al. Risk reduction in pleural procedures: sonography, simulation and supervision. Curr Opin Pulm Med 2010;16:340-350.
14. Van Meter ME, McKee KY, Kohlwes RJ. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med 2011;26:70-76.
15. Morel A, Mishra E, Medley L, et al. Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion. Thorax In press.
16. Janes SM, Rahman NM, Davies RJ, et al. Catheter-tract metastases associated with chronic indwelling pleural catheters. Chest 2007;131: 1232-1234. (Pubitemid 46608729)
17. Jimenez CA, Mhatre AD, Martinez CH, et al. Use of an indwelling pleural catheter for the management of recurrent chylothorax in patients with cancer. Chest 2007;132:1584-1590. (Pubitemid 350156016)
18. Davies HE, Lee YCG. Pleurodesis. In RW Light, YCG Lee, eds. Textbook of Pleural Diseases. London, UK: Arnold Press, 2008. Pp. 569-582.
19. Hooper CE, Lee YCG, Maskell NA. Setting up a specialist pleural disease service. Respirology 2010;15:1028-1036.
20. Duncan DR, Morgenthaler TI, Ryu JH, et al. Reducing iatrogenic risk in thoracentesis: establishing best practice via experiential training in a zero-risk environment. Chest 2009;135:1315-1320.
21. Patz EF Jr. Malignant pleural effusions: recent advances and ambulatory sclerotherapy. Chest 1998;113:74S-77S. (Pubitemid 28051739)
22. Reddy C, Ernst A, Lamb C, et al. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest In press.
23. Mercky P, Sakr L, Heyries L, et al. Use of a tunnelled pleural catheter for the management of refractory hepatic hydrothorax: a new therapeutic option. Respiration 2010;80:348-352.
24. Davies HE, Rahman NM, Parker RJ, et al. Use of indwelling pleural catheters for chronic pleural infection. Chest 2008;133:546-549. (Pubitemid 351272416)
25. Lee YCG, Lane KB. The many faces of transforming growth factor beta in pleural diseases. Curr Opin Pulm Med 2001;7:173-179. (Pubitemid 32675380)
26. Bethune N. Pleural poudrage. A new technique for the deliberate production of pleural adhesion as a preliminary to lobectomy. J Thorac Surg 1935;4:251-261.
27. Lee YCG, Wilkosz S. Malignant pleural effusions: fixing the leaky faucet. Am JRespir Crit Care Med 2008;178:3-5. (Pubitemid 351919185)